Effectiveness and Safety of First-Generation Protease Inhibitors in Real-World Patients With Hepatitis C Virus Genotype 1 Infection in Brazil: A Multicenter Study. Clinics 2017, 72 (6), 378-385. https://doi.org/10.6061/clinics/2017(06)08.